{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:16:13Z","timestamp":1789049773623,"version":"build-2803163510"},"posted":{"date-parts":[[2026,9,7]]},"group-title":"Bioengineering","reference-count":56,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"id":[{"id":"https:\/\/ror.org\/03m2x1q45","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Technology and Research Initiative Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,9,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Nanomedicines that perform well in conventional cell cultures often fail to translate into patients, in part due to the inability to reproduce the protein corona, and hence the biological identity, that nanoparticles acquire within the tumor microenvironment (TME). Here, we establish patient-derived colonic organoids (PDCOs) as a platform for profiling nano-bio interactions under physiologically tumor-relevant conditions using graphene quantum dots (GQD) and Silicon Quantum Dots (SiQD) as material-distinct probes. By combining spectral flow cytometry, confocal imaging, dynamic light scattering, and multi-spectral dimension-reduction analysis of single-cell uptake, we resolve how nanoparticle identity, uptake, and intracellular fate diverge between conventional culture and patient tissue. Conventional two-dimensional culture overestimated internalization by two-fold relative to ex vivo PDCOs, while TME-specific proteins directed nanoparticles to distinct organoid subpopulations. Exploiting this, we engineer the protein corona with tumor-specific proteins to redirect SiQDs to chemoresistant cells, from 3.8% to 70%, an 18-fold increase in targeted delivery to the cells that drive therapy resistance. Internalization was also model-dependent. PDCOs and fibroblasts favored clathrin\/dynamin (DNM1)-mediated endocytosis into lysosomes, whereas cancer cells favored caveolae (CAV1)-mediated entry that bypasses lysosomal degradation. This distinction determines whether a nanocarrier is degraded or delivered intact. Collectively, these findings turn the protein corona into a programmable design tool and establish PDCOs as a next-generation platform for precision nano-oncology.<\/jats:p>\n                <jats:sec>\n                  <jats:title>Graphical Abstract<\/jats:title>\n                  <jats:fig id=\"ufig1\" position=\"float\" orientation=\"portrait\" fig-type=\"figure\">\n                    <jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"749195v1_ufig1\" position=\"float\" orientation=\"portrait\"\/>\n                  <\/jats:fig>\n                <\/jats:sec>","DOI":"10.64898\/2026.09.03.749195","type":"posted-content","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:55:36Z","timestamp":1788818136000},"source":"Crossref","is-referenced-by-count":0,"title":["Patient-Derived Organoids as a Model to Understand Tumor Microenvironment-Driven Nano-Bio Interactions \u2013 A Framework Towards Improved Nanomedicine Translation"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6034-0169","authenticated-orcid":false,"given":"Meenu Priya","family":"Resmi","sequence":"first","affiliation":[{"name":"Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, Arizona, United States"},{"name":"University of Arizona Cancer Center, Tucson, Arizona, United States"},{"name":"BIO5 Institute, University of Arizona, Tucson, Arizona, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2265-4657","authenticated-orcid":false,"given":"Jayati","family":"Chakrabarti","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, Arizona, United States"},{"name":"University of Arizona Cancer Center, Tucson, Arizona, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0519-4679","authenticated-orcid":false,"given":"Kelvin W","family":"Pond","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, Arizona, United States"},{"name":"University of Arizona Cancer Center, Tucson, Arizona, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9874-3018","authenticated-orcid":false,"given":"Swarna","family":"Ganesh","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, Arizona, United States"},{"name":"Department of Biomedical Engineering, University of Arizona College of Engineering, Tucson, Arizona, United States"},{"name":"University of Arizona Cancer Center, Tucson, Arizona, United States"},{"name":"BIO5 Institute, University of Arizona, Tucson, Arizona, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026091007000697000_2026.09.03.749195v1.1","doi-asserted-by":"crossref","unstructured":"Yaghmur, A. ; \u00d8stergaard, J. ; Mu, H . Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers. Advanced drug delivery reviews 2023, 115136.","DOI":"10.1016\/j.addr.2023.115136"},{"key":"2026091007000697000_2026.09.03.749195v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01889-y"},{"key":"2026091007000697000_2026.09.03.749195v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2023.102290"},{"key":"2026091007000697000_2026.09.03.749195v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.114083"},{"key":"2026091007000697000_2026.09.03.749195v1.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-025-00847-2"},{"key":"2026091007000697000_2026.09.03.749195v1.6","doi-asserted-by":"publisher","DOI":"10.5599\/admet.1513"},{"key":"2026091007000697000_2026.09.03.749195v1.7","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-020-00740-5"},{"key":"2026091007000697000_2026.09.03.749195v1.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63726-2"},{"key":"2026091007000697000_2026.09.03.749195v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.10.023"},{"key":"2026091007000697000_2026.09.03.749195v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2020.12.108"},{"key":"2026091007000697000_2026.09.03.749195v1.11","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402935"},{"key":"2026091007000697000_2026.09.03.749195v1.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-025-01951-y"},{"key":"2026091007000697000_2026.09.03.749195v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2024.05.003"},{"key":"2026091007000697000_2026.09.03.749195v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116627"},{"key":"2026091007000697000_2026.09.03.749195v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.02.020"},{"key":"2026091007000697000_2026.09.03.749195v1.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.02.004"},{"key":"2026091007000697000_2026.09.03.749195v1.17","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2016.269"},{"key":"2026091007000697000_2026.09.03.749195v1.18","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.Targ-25-c127"},{"key":"2026091007000697000_2026.09.03.749195v1.19","doi-asserted-by":"publisher","DOI":"10.1038\/s44385-025-00041-x"},{"issue":"5","key":"2026091007000697000_2026.09.03.749195v1.20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/md19050282","article-title":"Gut Organoid as a New Platform to Study Alginate and Chitosan Mediated PLGA Nanoparticles for Drug Delivery","volume":"19","year":"2021","journal-title":"Marine Drugs"},{"key":"2026091007000697000_2026.09.03.749195v1.21","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao2774"},{"key":"2026091007000697000_2026.09.03.749195v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2018.01.024"},{"key":"2026091007000697000_2026.09.03.749195v1.23","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.78837"},{"key":"2026091007000697000_2026.09.03.749195v1.24","doi-asserted-by":"publisher","DOI":"10.64898\/2026.04.02.715982"},{"key":"2026091007000697000_2026.09.03.749195v1.25","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.3c00329"},{"key":"2026091007000697000_2026.09.03.749195v1.26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0805135105"},{"key":"2026091007000697000_2026.09.03.749195v1.27","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c08005"},{"key":"2026091007000697000_2026.09.03.749195v1.28","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202000285"},{"key":"2026091007000697000_2026.09.03.749195v1.29","doi-asserted-by":"publisher","DOI":"10.3390\/nano12040682"},{"key":"2026091007000697000_2026.09.03.749195v1.30","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2490235"},{"key":"2026091007000697000_2026.09.03.749195v1.31","doi-asserted-by":"publisher","DOI":"10.1002\/admi.201901386"},{"key":"2026091007000697000_2026.09.03.749195v1.32","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S254808"},{"key":"2026091007000697000_2026.09.03.749195v1.33","doi-asserted-by":"publisher","DOI":"10.1021\/cbe.4c00105"},{"issue":"12","key":"2026091007000697000_2026.09.03.749195v1.34","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.3390\/pharmaceutics14122605","article-title":"Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune System","volume":"14","year":"2022","journal-title":"Pharmaceutics"},{"key":"2026091007000697000_2026.09.03.749195v1.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114635"},{"key":"2026091007000697000_2026.09.03.749195v1.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42604-0"},{"key":"2026091007000697000_2026.09.03.749195v1.37","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.07.050"},{"key":"2026091007000697000_2026.09.03.749195v1.38","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S254808"},{"key":"2026091007000697000_2026.09.03.749195v1.39","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202403913"},{"key":"2026091007000697000_2026.09.03.749195v1.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-021-00550-0"},{"key":"2026091007000697000_2026.09.03.749195v1.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2022.04.005"},{"key":"2026091007000697000_2026.09.03.749195v1.42","doi-asserted-by":"crossref","unstructured":"Sharma, G. ; Goyal, Y. ; Bhatia, S . Preclinical Animal Models of Cancer: Applications and Limitations. In Handbook of Animal Models and its Uses in Cancer Research, Pathak, S. , Banerjee, A. , Bisgin, A. Eds.; Springer Nature Singapore, 2022; pp 1\u201321.","DOI":"10.1007\/978-981-19-1282-5_54-1"},{"key":"2026091007000697000_2026.09.03.749195v1.43","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2025.1498141"},{"key":"2026091007000697000_2026.09.03.749195v1.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2018.11.3134"},{"key":"2026091007000697000_2026.09.03.749195v1.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2013.10.013"},{"key":"2026091007000697000_2026.09.03.749195v1.46","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.0c09649"},{"key":"2026091007000697000_2026.09.03.749195v1.47","doi-asserted-by":"publisher","DOI":"10.1002\/mabi.202000414"},{"key":"2026091007000697000_2026.09.03.749195v1.48","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02363-1"},{"issue":"11","key":"2026091007000697000_2026.09.03.749195v1.49","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3390\/cancers13112748","article-title":"EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance","volume":"13","year":"2021","journal-title":"Cancers"},{"key":"2026091007000697000_2026.09.03.749195v1.50","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2014.156"},{"key":"2026091007000697000_2026.09.03.749195v1.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2017.09.008"},{"key":"2026091007000697000_2026.09.03.749195v1.52","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2017.132"},{"key":"2026091007000697000_2026.09.03.749195v1.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110399"},{"key":"2026091007000697000_2026.09.03.749195v1.54","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.2c00537"},{"key":"2026091007000697000_2026.09.03.749195v1.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmt.2022.101534"},{"key":"2026091007000697000_2026.09.03.749195v1.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2023.102289"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.09.03.749195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:00:14Z","timestamp":1789048814000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.09.03.749195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":56,"URL":"https:\/\/doi.org\/10.64898\/2026.09.03.749195","relation":{},"subject":[],"published":{"date-parts":[[2026,9,7]]},"subtype":"preprint"}}